Tag: Indian Pharma
Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment
Emcure Pharmaceuticals Ltd announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
CDSCO Clarifies Approval Rules for Granules & Pellets, Bringing Regulatory Clarity to Pharma Industry
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a comprehensive circular clarifying the regulatory and licensing...
12 Years, One Mission: Affordable Medicines and a Stronger Pharma Future for India
India’s pharmaceutical sector has witnessed remarkable growth over the past 12 years, driven by initiatives aimed at expanding healthcare access, strengthening domestic manufacturing, and...